Yale Study Links Genetics and Blood Pressure Control in Stroke Survivors
Stroke survivors face an increased risk of suffering a second stroke and developing cognitive disabilities as a result. Evidence indicates that hypertension plays a significant role in this comorbidity, and yet, only 60% of stroke survivors have their blood pressure under control. A Yale-led study studies the link between elevated genetic predisposition to hypertension and more-difficult-to-control blood pressure.
Julian Acosta, MD Wins 2022 Paul Dudley White International Scholar Award
Julian Acosta, MD has been selected for the American Heart Association's Paul Dudley White International Scholar Award for the abstract, "“Observed and Genomic Life’S Simple 7 Influence Brain Health-related Neuroimaging Traits in Persons Without Stroke Or Dementia,” on which which Dr. Acosta was primary author.
Bedside point-of-care MRI appears convenient and accurate
In one of the first deployments of a point-of-care MRI scanner, Dr. Kevin Sheth of Yale School of Medicine discussed the application of low-field POC MRI, outlining the constraints of conventional MRI and advantages of MRI at the bedside.Source: AuntMinnie.com
NICU & Stroke Team to Present, Receive Awards at International Stroke Conference
Researchers at the Yale School of Medicine’s Neurointensive Care Unit (NICU) and Stroke division will present new, scientific findings and receive several major awards at the International Stroke Conference in Los Angeles from February 19 – 21, 2020.
Yale Faculty Pioneer Development and Testing of Portable MRI Device
Yale researchers have agreed to develop, deploy, and test a new portable MRI scanner, a device its developer hopes will cost a fraction of that of traditional MRIs and make the new imaging technology available in clinics in the U.S. and around the world.
How Brain Regions Involved in Wakeful Rest May Play a Role in the Risk for Alzheimer’s Disease
Daydreaming puts the brain in a state of wakeful rest, allowing the connection of brain regions known as the Default Mode Network (DMN) to interact. The DMN is now a topic of investigation for researchers trying to understand why women are at a higher risk for Alzheimer's Disease than men.
Study Identifies Neuronal Basis of Impaired Consciousness in Absence Epilepsy
Using a genetic model known as Genetic Absence Epilepsy Rats of Strasbourg (GAERS), Yale researchers have identified the neuronal basis for absence epilepsy. Their findings were published Jan. 10 in Nature Communications. During absence epilepsy episodes, children experience brief staring spells, during which they temporarily lose consciousness. Absence seizures can be captured by abnormal rhythms on EEG recordings, but their neuronal cause has never before been identified.
Céline Dion has stiff person syndrome, a rare neurological disorder. What is that?
Following Celine Dion's diagnosis of Stiff Person Syndrome, neurologists like Yale assistant professor Kunal Desai, MD, weigh in on the causes, symptoms, and treatments of SPS, as well as whether the neuromuscular condition affects lifespan.Source: USA Today
What is Stiff Person Syndrome?
Following Celine Dion's diagnosis of Stiff Person Syndrome, neurologists like Yale assistant professor Richard Nowak, MD, MS, weigh in on the causes, symptoms, and treatment options for this neuromuscular condition, as well as whether or not if affects lifespan.Source: New York Times
What is stiff-person syndrome? Celine Dion reveals rare condition.
Following Celine Dion's diagnosis of Stiff Person Syndrome, neurologists, including Yale assistant professor Kunal Desai, MD, weigh in on the neuromuscular condition's causes, symptoms, and treatment options, as well as whether the condition affects lifespan.Source: Washington Post
Celine Dion has stiff-person syndrome, a one-in-a-million diagnosis. These are its symptoms.
Following Celine Dion's diagnosis of Stiff Person Syndrome, neurologists like Yale assistant professor Richard Nowak, MD, MS weigh in on the causes, symptoms, and treatments of this neuromuscular condition, as well as whether it affects lifespan.Source: NBC News
Veronica Santini, MD Elucidates Autonomic Dysfunction at Parkinson’s Disease Webinar
On November 22, the American Parkinson Disease Association (APDA) Connecticut Chapter featured Veronica Santini, MD, who presented “Autonomic Dysfunction in Parkinson’s Disease” for the Association’s Summer/Fall 2022 Parkinson’s Education Series. This important webinar shed light on some of the more insidious symptoms of Parkinson’s disease (PD) that often go undetected and undertreated. The pathophysiology, signs and symptoms, and available treatments were comprehensively reviewed for the virtual audience, which included people with PD, caregivers, advocates, and healthcare professionals.
Cedarbaum Presents on Current Research, Technological Advancements for Parkinson’s Disease
Jesse Cedarbaum, professor adjunct of neurology and psychiatry at Yale, presented in the American Parkinson Disease Association September webinar series, “Preventing Parkinson’s Disease: The Long and Winding Road that Leads to YOUR Door." Dr. Cedarbaum gave an overview of current and future research in Parkinson's disease, as well as developments in technology designed to manage syptoms in patients.
"Fitness Counts" Unites Parkinson’s Disease Researchers and Activists
The Yale Movement Disorders Division joined forces with the Parkinson’s Foundation at an event entitled “Fitness Counts” on October 14, 2022. The event featured remarks by Yale's Veronica Santini, Sule Tinaz, and Christine Gummerson, as well as Beat PD Today founder Michelle Hespeler.
Research Applies Machine Learning/AI to Predict Consciousness for Driving in People with Epilepsy
A new study published in September 2022 in Annals of Clinical and Translational Neurology may guide doctors in how to proceed when they observe SWDs on EEG, but are unclear of the patient’s neurological capacity for driving. Led by Principal Investigator Hal Blumenfeld, MD, PhD, researchers have harnessed the power of machine learning/artificial intelligence (AI) to address the shortcomings of traditional testing.